💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

Egetis Therapeutics AB (publ) (EGTX)

Stockholm
Currency in SEK
Disclaimer
5.64
+0.03(+0.53%)
Real-time Data
EGTX Scorecard
Full Analysis
Suffers from weak gross profit margins
Fair Value
Day's Range
5.475.64
52 wk Range
3.839.30
Bid/Ask
5.60 / 5.65
Prev. Close
5.61
Open
5.47
Day's Range
5.47-5.64
52 wk Range
3.83-9.3
Volume
52,813
Average Volume (3m)
712,678
1-Year Change
42.03%
Fair Value
Unlock
Fair Value Upside
Unlock
EGTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
11.40
Upside
+102.13%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Egetis Therapeutics AB (publ) Company Profile

Egetis Therapeutics AB (publ), a pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a highly debilitating rare disease with no available treatment. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.

Employees
25
Market
Sweden

Compare EGTX to Peers and Sector

Metrics to compare
EGTX
Peers
Sector
Relationship
P/E Ratio
−5.1x−2.8x−0.6x
PEG Ratio
−0.73−0.040.00
Price/Book
4.1x2.3x2.6x
Price / LTM Sales
23.2x14.1x3.1x
Upside (Analyst Target)
113.9%138.2%58.3%
Fair Value Upside
Unlock24.2%8.8%Unlock

FAQ

What Is the Egetis Therapeutics AB (EGTX) Stock Price Today?

The Egetis Therapeutics AB stock price today is 5.64

What Stock Exchange Does Egetis Therapeutics AB Trade On?

Egetis Therapeutics AB is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Egetis Therapeutics AB?

The stock symbol for Egetis Therapeutics AB is "EGTX."

What Is the Egetis Therapeutics AB Market Cap?

As of today, Egetis Therapeutics AB market cap is 1.63B.

What is Egetis Therapeutics AB Earnings Per Share?

The Egetis Therapeutics AB EPS is -1.14.

What Is the Next Egetis Therapeutics AB Earnings Date?

Egetis Therapeutics AB will release its next earnings report on Nov 06, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.